CREB, a transcription factor, is involved in the tumorigenicity of HER2/Neu-overexpressing tumor cells [32, 33]; VEGF, a CREB target gene, is associated with tumor angiogenesis, metastatic growth, and poor prognosis in breast cancer [34–36]. This evidence concerns the gene ERBB2 and breast cancer.